CIK 0001628171 · Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472029180
- Phone
- 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $85,328,124
- in 21 filings, $85.3M under 10b5-1 plans
Net −$85,328,124. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-01 | Anders Jack Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +45,400 | 45,400 | ||
| 2026-02-06 | GOLDSMITH MARK A See Remarks | Option exercise | +24,010 | $0.54 | $13K | 256,479 |
| 2026-02-06 | GOLDSMITH MARK A See Remarks | Option exercise · Stock Option (Right to Buy) | −24,010 | 144,493 | ||
| 2026-01-21 | Cislini Jeff General Counsel | Sale 10b5-1 | −908 | $115.60 | $105K | 46,976 |
| 2026-01-07 | Horn Margaret A Chief Operating Officer | Option exercise 10b5-1 | +51,406 | $42.45 | $2.2M | 192,459 |
| 2026-01-07 | Horn Margaret A Chief Operating Officer | Option exercise 10b5-1 | +23,594 | $29.80 | $703K | 216,053 |
| 2026-01-07 | Horn Margaret A Chief Operating Officer | Sale 10b5-1 | −53,096 | $100.02 | $5.3M | 162,957 |
| 2026-01-07 | Horn Margaret A Chief Operating Officer | Sale 10b5-1 | −20,204 | $101.79 | $2.1M | 142,753 |
| 2026-01-07 | Horn Margaret A Chief Operating Officer | Sale 10b5-1 | −1,700 | $102.90 | $175K | 141,053 |
| 2026-01-07 | Horn Margaret A Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −51,406 | 1,094 | ||
| 2026-01-07 | Horn Margaret A Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −23,594 | 119,906 | ||
| 2026-01-07 | Anders Jack Chief Financial Officer | Option exercise 10b5-1 | +10,000 | $42.45 | $425K | 118,065 |
| 2026-01-07 | Anders Jack Chief Financial Officer | Sale 10b5-1 | −10,000 | $98.00 | $980K | 108,065 |
| 2026-01-07 | Anders Jack Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 15,900 | ||
| 2025-12-16 | Cislini Jeff General Counsel | Sale 10b5-1 | −2,688 | $76.82 | $206K | 47,884 |
| 2025-12-16 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −15,394 | $76.82 | $1.2M | 232,469 |
| 2025-12-16 | Kelsey Stephen Michael See Remarks | Sale 10b5-1 | −5,447 | $76.82 | $418K | 278,600 |
| 2025-12-16 | Horn Margaret A Chief Operating Officer | Sale 10b5-1 | −4,847 | $76.82 | $372K | 141,053 |
| 2025-12-16 | Anders Jack Chief Financial Officer | Sale 10b5-1 | −3,104 | $77.09 | $239K | 108,065 |
| 2025-11-25 | Anders Jack Chief Financial Officer | Option exercise 10b5-1 | +5,418 | $17.00 | $92K | 116,412 |
Page 13 of 18 · 352 trades